Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

29 y/o Male w/ CML: Allograft vs. 3rd Line Therapy - Transplant Is Always Relevant, Ponatinib Raises Concerns in Long-term Use, Asciminib Safe & Active in MDR AML

16 views
November 18, 2019
Comments 0
Login to view comments. Click here to Login